𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan

✍ Scribed by Morihiko Kimura; Takeshi Tominaga; Yuichi Takatsuka; Masakazu Toi; Rikiya Abe; Hiroki Koyama; Shigemitsu Takashima; Yasuo Nomura; Shigeto Miura; Izo Kimijima; Hideya Tashiro; Yasuo Ohashi; Adjuvant CEF Research Group for Breast Cancer

Book ID
107643758
Publisher
Springer Japan
Year
2009
Tongue
English
Weight
224 KB
Volume
17
Category
Article
ISSN
1340-6868

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Randomized trial comparing cyclophospham
Randomized trial comparing cyclophosphamide, methotrexate, and 5–fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinoma
✍ Giorgio Cocconi; Beatrice Di Blasio; Corrado Boni; Giancarlo Bisagni; Guido Ceci πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 84 KB

## Abstract ## BACKGROUND According to the overview of Early Breast Cancer Trialists' Collaborative Group, anthracycline containing regimens are superior to cyclophosphamide, methotrexate, and 5–fluorouracil (CMF) as adjuvant chemotherapy for breast carcinoma, but no comparative information is ava

Combination chemotherapy for metastatic
Combination chemotherapy for metastatic breast cancer with fluorouracil, adriamycin, cyclophosphamide, and methotrexate
✍ Ambrose Aboud; Aman U. Buzdar; Hwee-Yong Yap; Gabriel N. Hortobagyi; George R. B πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 270 KB

Twenty-nine patients with metastatic breast cancer were treated with fluorouracil, adriamycin, cyclophosphamide (FAC), and methotrexate (MTX), with or without leukovorin rescue. Of 24 evaluable patients, one achieved a complete remission and 17 had partial responses. The overall objective response r